As of Jan 19
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +238.35% increase from the last price of 2.66.
The current consensus among 5 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.